Alcoholic Hepatitis - ECAB

Alcoholic Hepatitis - ECAB
Author: Philip Abraham
Publisher: Elsevier Health Sciences
Total Pages: 110
Release: 2008-12-29
Genre: Medical
ISBN: 8131231879

Alcoholic hepatitis involves an acute or chronic inflammation of liver occurring as a consequence of alcohol abuse The pathological changes occur in 3 stages namely, fatty liver, alcoholic hepatitis and cirrhosis, with the final stage traditionally considered to be irreversible Alcoholic liver disease is responsible for a significant number of premature deaths per annum all around the globe There is an urgent need to educate the masses about the hazards of alcohol abuse An efficient system to encourage and prolong the period of alcohol abstinence is the need of the hour The importance of lifestyle modifications like weight reduction and cessation of smoking in the progression of liver disease needs to be communicated to the patients and the medical community as well Moreover, realization of the role of nutrition in the management and recovery of ALD would enhance the treatment strategies for this condition This book has been designed to update the readers on the important aspects of ALD and is a step forward to enable the society in combating the social and economic losses that occur as a result of alcohol abuse The book has stressed upon various aspects of ALD like the role of nutrition, epidemiology and pathogenesis, and the possible therapeutic strategies involved Supportive case scenarios have also been incorporated with relevance to the topics covered under the book Overall, the book presents to the readers an excellent compilation of clinically applicable literature sourced from the most acclaimed physicians in the country

Alcoholic Liver Disease - ECAB

Alcoholic Liver Disease - ECAB
Author: Philip Abraham
Publisher: Elsevier Health Sciences
Total Pages: 168
Release: 2009-09-15
Genre: Medical
ISBN: 8131231844

Alcoholic liver disease involves an acute or chronic inflammation of liver occurring as a consequence of alcohol abuse. The pathological changes occur in 3 stages namely, fatty liver, alcoholic liver disease and cirrhosis, with the final stage traditionally considered to be irreversible. Alcoholic liver disease is responsible for a significant number of premature deaths per annum all around the globe. There is an urgent need to educate the masses about the hazards of alcohol abuse. An efficient system to encourage and prolong the period of alcohol abstinence is the need of the hour. The importance of lifestyle modifications like weight reduction and cessation of smoking in the progression of liver disease needs to be communicated to the patients and the medical community as well. Moreover, realization of the role of nutrition in the management and recovery of ALD would enhance the treatment strategies for this condition. This book has been designed to update the readers on the important aspects of ALD and is a step forward to enable the society in combating the social and economic losses that occur as a result of alcohol abuse. The book has stressed upon various aspects of ALD like the role of nutrition, epidemiology and pathogenesis, and the possible therapeutic strategies involved. Supportive case scenarios have also been incorporated with relevance to the topics covered under the book. Overall, the book presents to the readers an excellent compilation of clinically applicable literature sourced from the most acclaimed physicians in the country.

Hepatitis - ECAB

Hepatitis - ECAB
Author: Abhijit Chowdhury
Publisher: Elsevier Health Sciences
Total Pages: 138
Release: 2009-07-15
Genre: Medical
ISBN: 8131231860

Hepatitis means inflammation of the liver, which can be classified as acute or chronic depending upon the duration of the condition. Various etiological agents have been correlated with the occurrence of various forms of the disease. The developed countries have a majority of drug-induced and toxic liver injury, while the developing countries like India present with a majority of feco-oral and blood borne transmissions of the disease. Viral hepatitis virtually constitutes a separate etiological group. It causes a set of typical clinical, biochemical, and histological changes with or without icterus resulting from hepatic cell damage. It may be acute or chronic. The acute form causes considerable morbidity and mortality, and the chronic sequelae may prove to be fatal by resulting in liver cirrhosis and hepatocellular carcinoma (HCC). Hepatitis A and E are transmitted feco-orally, while B and C are transmitted only through blood/secretions. Hepatitis D occurs only in association with hepatitis B. Morphological pattern of liver injury in acute hepatitis varies with etiology and severity of insult. The typical lesion in all forms of acute viral hepatitis is panlobular infiltration with mononuclear cells, predominantly lymphocytes, hepatic cell necrosis, and variable degree of cholestasis, Kupffer cell hyperplasia. In fulminant hepatic failure, massive hepatic necrosis results in a soft shrunken liver. All forms of acute viral hepatitis run similar clinical course, which include incubation period after infection during which they are asymptomatic, followed by prodromal, icteric, and convalescent phases. Extrahepatic manifestations of viral hepatitis include renal, neurological, and hematological disorders. Most patients with acute viral hepatitis recover with supportive management. Hospitalization is required only in severe cases as evidenced by prolonged PT, altered sensorium, deep jaundice with ascites. Identification of etiology of acute hepatitis is of prime importance for the treatment of hepatitis. Definitive therapy is needed in drug-induced hepatitis. Most mild forms of viral hepatitis resolve with supportive treatment. Progressive liver failure mandates urgent liver transplantation. Prognostic models (Kings’ College criteria, Clichy’s criteria) have been developed for early identification of patients who would require liver transplant.

ECAB Clinical Hepatology - E-Book

ECAB Clinical Hepatology - E-Book
Author: Deepak Amarapurkar
Publisher: Elsevier Health Sciences
Total Pages: 137
Release: 2014-12-11
Genre: Medical
ISBN: 8131239543

ECAB Clinical Hepatology - E-Book

Hepatic Encephalopathy - ECAB

Hepatic Encephalopathy - ECAB
Author: Prabha Sawant
Publisher: Elsevier Health Sciences
Total Pages: 104
Release: 2013-06-17
Genre: Medical
ISBN: 8131231836

Hepatic encephalopathy is the clinical syndrome resulting from increased ammonia levels in blood. The most common cause of HE is chronic liver disease. However, acute liver failure, Reye’s syndrome, or metabolic defects are other causes. The true prevalence of overt HE is difficult to establish because of the considerable heterogeneity in etiology and disease severity. However, HE has been reported to be present in around 50% of patients with cirrhosis or with porto-caval shunts at some time during their illness. It is less common in patients with portosystemic shunts without liver disease. Thirty percent of patients dying of end-stage liver disease experience significant encephalopathy, approaching coma. After TIPS placement, approximately 1/3 of patients will experience overt HE. Minimal HE (MHE) is difficult to diagnose due to lack of standard diagnostic tests. Its clinical significance with regards to progression to overt encephalopathy has however, not been established. Conventional treatment of hepatic encephalopathy relies primarily on reducing the production and absorption of ammonia. Identification and correction of the precipitating factors and general supportive measures are important management steps. There are very few randomized controlled trials (RCT) of therapies and even these are bugged by lack of a control group and small sample sizes.

Medicine Update 2019 & Progress in Medicine 2019

Medicine Update 2019 & Progress in Medicine 2019
Author: KK Pareek
Publisher: Jaypee Brothers Medical Publishers
Total Pages: 750
Release: 2019-05-31
Genre: Medical
ISBN: 935270522X

(Medicine Update 2019_2 Volumes) SECTION 1: CARDIOLOGY SECTION 2: HYPERTENSION SECTION 3: PULMONOLOGY SECTION 4: ENDOCRINOLOGY SECTION 5: DIABETOLOGY SECTION 6: NEUROLOGY SECTION 7: RHEUMATOLOGY SECTION 8: NEPHROLOGY SECTION 9: GASTROENTEROLOGY AND HEPATOLOGY SECTION 10: ONCOLOGY AND HEMATOLOGY SECTION 11: INFECTIOUS DISEASES SECTION 12: CRITICAL CARE MEDICINE SECTION 13: POISIONING AND TOXICOLOGY SECTION 14: PREGNANCY SECTION 15: HIV SECTION 16: GERIATRICS SECTION 17: LIPIDOLOGY SECTION 18: NUTRITION SECTION 19: ENVIRONMENTAL MEDICINE SECTION 20: MISCELLANEOUS (Progress in Medicine 2019) SECTION 1: CARDIOLOGY SECTION 2: ENDOCRINOLOGY AND DIABETOLOGY SECTION 3: GASTROENTEROLOGY SECTION 4: GERIATRICS SECTION 5: GENERAL MEDICINE SECTION 6: INFECTIOUS DISEASES SECTION 7: NEPHROLOGY SECTION 8: NEUROLOGY SECTION 9: ONCOLOGY SECTION 10: PULMONOLOGY SECTION 11: POISONING SECTION 12: RABINDRANATH TAGORE ORATION SECTION 13: RHEUMATOLOGY Index